Cargando…
Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma
OBJECTIVE: Besides breast and gastric cancer, HER2 amplification/mutation are also found in lung adenocarcinoma (LUAD). However, the correlation between HER2 variations and the phenotype of immunogenicity and tumor immune microenvironment (TIME) in LUAD compared with breast and gastric cancer has ye...
Autores principales: | Wang, Qinyang, Mao, Ziyang, Li, Wenyuan, Wang, Shumei, Wang, Lei, Chen, Lin, Yang, Zhe, Fu, Xiaolan, Jiang, Panpan, Bai, Yixue, Xu, Longwen, Zhang, Shirong, Hou, Yuzhu, Jia, Xiaohui, Jiang, Lili, Liu, Mengjie, Zhang, Guanjun, Jiang, Yina, Guo, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797999/ https://www.ncbi.nlm.nih.gov/pubmed/36591290 http://dx.doi.org/10.3389/fimmu.2022.1042072 |
Ejemplares similares
-
Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Mao, Ziyang, et al.
Publicado: (2022) -
First‐line immune‐based combination therapies for advanced non‐small cell lung cancer: A Bayesian network meta‐analysis
por: Mao, Ziyang, et al.
Publicado: (2021) -
An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer
por: Jiang, Panpan, et al.
Publicado: (2021) -
ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022) -
HER-3 expression in HER-2-amplified breast carcinoma
por: Czopek, Jacek, et al.
Publicado: (2013)